2Degenhardt, L, Hall, W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012; 379: 55–70.
3Mattick, RP, Breen, C, Kimber, J, Davoli, M, Richard, PM, Breen, C, et al. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2003; 2: .
4Rosic, T, Naji, L, Bawor, M, Dennis, B, Plater, C, Marsh, D, et al. The impact of comorbid psychiatric disorders on methadone maintenance treatment in opioid use disorder: a prospective cohort study. Neuropsychiatr Dis Treat 2017; 13: 1399–408.
5Degenhardt, L, Whiteford, HA, Ferrari, AJ, Baxter, AJ, Charlson, FJ, Hall, WD, et al. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet 2013; 382: 1564–74.
6Blanco, C, Hasin, DS, Wall, MM, Flórez-Salamanca, L, Hoertel, N, Wang, S, et al. Cannabis use and risk of psychiatric disorders. JAMA Psychiatry 2016; 73: 388.
7Wittchen, HU, Fröhlich, C, Behrendt, S, Günther, A, Rehm, J, Zimmermann, P, et al. Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents. Drug Alcohol Depend 2007; 88: 60–70.
8Moore, THM, Zammit, S, Lingford-Hughes, A, Barnes, TRE, Jones, PB, Burke, M, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370: 319–28.
9Lucas, P. Rationale for cannabis-based interventions in the opioid overdose crisis. Harm Reduct J 2017; 14: 58.
10Raby, WN, Carpenter, KM, Rothenberg, J, Brooks, AC, Jiang, H, Sullivan, M, et al. Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependence. Am J Addict 2009; 18: 301–8.
11Scavone, JL, Sterling, RC, Weinstein, SP, Van Bockstaele, EJ. Impact of cannabis use during stabilization on methadone maintenance treatment. Am J Addict 2013; 22: 344–51.
12Olfson, M, Wall, MM, Liu, S-M, Blanco, C. Cannabis use and risk of prescription opioid use disorder in the United States. Am J Psychiatry 2018; 175: 47–53.
13Zielinski, L, Bhatt, M, Sanger, N, Plater, C, Worster, A, Varenbut, M, et al. Association between cannabis use and methadone maintenance treatment outcomes: an investigation into sex differences. Biol Sex Differ 2017; 8: 8.
14Samaan, Z, Bawor, M, Dennis, BB, Plater, C, Varenbut, M, Daiter, J, et al. Genetic influence on methadone treatment outcomes in patients undergoing methadone maintenance treatment for opioid addiction: a pilot study. Neuropsychiatr Dis Treat 2014; 10: 1503–8.
15American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision DSM-IV-TR. APA, 2000.
16Cleeland, CS, Ryan, KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994; 23: 129–38.
17Dennis, BB, Roshanov, PS, Bawor, M, Paul, J, Varenbut, M, Daiter, J, et al. Usefulness of the Brief Pain Inventory in patients with opioid addiction receiving methadone maintenance treatment. Pain Physician 2016; 19: E181–95.
18Sheehan, D, Lecrubier, Y, Sheehan, K, Amorim, P, Janavs, J, Weiller, E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatr 1998; 59: 22–33.
19Marsden, J, Gossop, M, Stewart, D, Best, D, Farrell, M, Strang, J. The Maudsley Addiction Profile: Development and User Manual. National Addiction Centre/ Institute of Psychiatry, 1998 (http://www.dldocs.stir.ac.uk/documents/Map.pdf).
20Harris, PA, Taylor, R, Thielke, R, Payne, J, Gonzalez, N, Conde, JG. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42: 377–81.
21Mariani, JJ, Brooks, D, Haney, M, Levin, FR. Quantification and comparison of marijuana smoking practices: blunts, joints, and pipes. Drug Alcohol Depend 2011; 113: 249–51.
22Palmer, RHC, Young, SE, Hopfer, CJ, Corley, RP, Stallings, MC, Crowley, TJ, et al. Developmental epidemiology of drug use and abuse in adolescence and young adulthood: evidence of generalized risk. Drug Alcohol Depend 2009; 102: 78–87.
23Pakula, B, Macdonald, S, Stockwell, T. Settings and functions related to simultaneous use of alcohol with marijuana or cocaine among clients in treatment for substance abuse. Subst Use Misuse 2009; 44: 212–26.
24Geels, LM, Vink, JM, van Beek, JH, Bartels, M, Willemsen, G, Boomsma, DI. Increases in alcohol consumption in women and elderly groups: evidence from an epidemiological study. BMC Public Health 2013; 13: 207.
25Wilsnack, RW, Vogeltanz, ND, Wilsnack, SC, Harris, TR, Ahlström, S, Bondy, S, et al. Gender differences in alcohol consumption and adverse drinking consequences: cross-cultural patterns. Addiction 2000; 95: 251–65.
26Keyes, KM, Grant, BF, Hasin, DS. Evidence for a closing gender gap in alcohol use, abuse, and dependence in the United States population. Drug Alcohol Depend 2008; 93: 21–9.
27Wasserman, DA, Weinstein, MG, Havassy, BE, Hall, SM. Factors associated with lapses to heroin use during methadone maintenance. Drug Alcohol Depend 1998; 52: 183–92.
28Epstein, DH, Preston, KL. Does cannabis use predict poor outcome for heroin-dependent patients on maintenance treatment? Past findings and more evidence against. Addiction 2003; 98: 269–79.
29Degenhardt, L, Hall, W. Is cannabis use a contributory cause of psychosis? Can J Psychiatry 2006; 51: 556–65.
30Crippa, JA, Zuardi, AW, Martín-Santos, R, Bhattacharyya, S, Atakan, Z, McGuire, P, et al. Cannabis and anxiety: a critical review of the evidence. Hum Psychopharmacol Clin Exp 2009; 24: 515–23.
31Cooper, ZD, Haney, M. Investigation of sex-dependent effects of cannabis in daily cannabis smokers. Drug Alcohol Depend 2014; 136: 85–91.
32Craft, RM, Marusich, JA, Wiley, JL. Sex differences in cannabinoid pharmacology: a reflection of differences in the endocannabinoid system? Life Sci 2013; 92: 476–81.
34Fattore, L. Considering gender in cannabinoid research: a step towards personalized treatment of marijuana addicts. Drug Test Anal 2013; 5: 57–61.
35Khan, SS, Secades-Villa, R, Okuda, M, Wang, S, Pérez-Fuentes, G, Kerridge, BT, et al. Gender differences in cannabis use disorders: results from the national epidemiologic survey of alcohol and related conditions. Drug Alcohol Depend 2013; 130: 101–8.
36Möller-Leimkühler, AM. Barriers to help-seeking by men: a review of sociocultural and clinical literature with particular reference to depression. J Affect Disord 2002; 71: 1–9.
37Urbanoski, K, Inglis, D, Veldhuizen, S. Service use and unmet needs for substance use and mental disorders in Canada. Can J Psychiatry 2017; 62: 551–9.
38Heath, PJ, Brenner, RE, Vogel, DL, Lannin, DG, Strass, HA. Masculinity and barriers to seeking counseling: the buffering role of self-compassion. J Couns Psychol 2017; 64: 94–103.
39Nugent, SM, Morasco, BJ, O'Neil, ME, Freeman, M, Low, A, Kondo, K, et al. The effects of cannabis among adults with chronic pain and an overview of general harms. Ann Intern Med 2017; 167: 319.
40Campbell, G, Hall, WD, Peacock, A, Lintzeris, N, Bruno, R, Larance, B, et al. Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study. Lancet Public Heal 2018; 3: e341–50.
41Deshpande, A, Mailis-Gagnon, A, Zoheiry, N, Lakha, SF. Efficacy and adverse effects of medical marijuana for chronic noncancer pain: systematic review of randomized controlled trials. Can Fam Physician 2015; 61: e372–81.
42Marconi, A, Di Forti, M, Lewis, CM, Murray, RM, Vassos, E. Meta-analysis of the association between the level of cannabis use and risk of psychosis. Schizophr Bull 2016; 42: 1262–9.
43Di Forti, M, Marconi, A, Carra, E, Fraietta, S, Trotta, A, Bonomo, M, et al. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. Lancet Psychiatry 2015; 2: 233–8.
44Peles, E, Schreiber, S, Sason, A, Adelson, M. Earning “take-home” privileges and long-term outcome in a methadone maintenance treatment program. J Addict Med 2011; 5: 92–8.
45Kidorf, M, Neufeld, K, King, VL, Clark, M, Brooner, RK. A stepped care approach for reducing cannabis use in opioid-dependent outpatients. J Subst Abuse Treat 2007; 32: 341–7.